NCT05729009 The Evolution of Systemic Microvascular Reactivity in Heart Transplant Patients
| NCT ID | NCT05729009 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Cardiology, Laranjeiras, Brazil |
| Condition | Heart Transplantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 31 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 31 participants in total. It began in 2022-10-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The evolution of systemic microvascular reactivity may aid in the comprehension of cardiovascular physiology in heart transplantation patients, and possibly suggest the non-invasive evaluation of skin microcirculation as an ancillary tool in the clinical evaluation of these patients.
Eligibility Criteria
Inclusion Criteria: * capability to understand the objectives of the research and to fulfill the Term of Consent Exclusion Criteria: * Pregnancy, acute infection diagnosis, use of circulatory assistance devices
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05729009 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Heart Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05729009 currently recruiting?
Yes, NCT05729009 is actively recruiting participants. Contact the research team at etibi@uol.com.br for enrollment information.
Where is the NCT05729009 trial being conducted?
This trial is being conducted at Rio de Janeiro, Brazil.
Who is sponsoring the NCT05729009 clinical trial?
NCT05729009 is sponsored by National Institute of Cardiology, Laranjeiras, Brazil. The trial plans to enroll 31 participants.